Propel Bio Management, LLC PHAT Holdings History
Propel Bio Management, LLC's Phathom Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Propel Bio Management, LLC held 1.13 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $7.12 Mil. This investment constitutes 8.37% of their stock portfolio, and Propel Bio Management, LLC now holds 1.63% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.
The initial trade took place in 2023Q4. And since then Propel Bio Management, LLC has made 3 purchases of PHAT, at an average price of $8.64, for a total of 1.13 Mil shares. Based on historical transaction data and PHAT's current price of $9.02, Propel Bio Management, LLC's estimated gain on his PHAT holdings is $436,415.20, reflecting a 4.45% gain to date.
Propel Bio Management, LLC PHAT ($9.02) Holding Chart
Propel Bio Management, LLC PHAT ($9.02) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
